Improving Results Through Better Understanding: A Primer On High-Dimensional Flow Cytometry Technologies And Reagents
In this webinar, Caroline Roe, Managing Director, Cancer and Immunology Core, Vanderbilt University, will give a broad overview of available high-dimensional flow cytometry technologies and reagents, how they work, and an experience-informed breakdown of the strengths and limitations of each technique. She will review considerations for choosing the appropriate high-dimensional flow cytometry technology for a project. In addition, she will provide guidance for those who have experience in one technology and are transitioning to another.
Key topics discussed in this webinar will include:
- An overview of high-dimensional flow cytometry technologies and reagents
- Considerations for choosing the appropriate high-dimensional flow cytometry technology for a project
- Guidance for those who are transitioning to a new flow cytometry technology
Who should attend?
- Flow cytometry novices who wish to learn more about high-dimensional flow cytometry
- Experienced flow cytometrists who are new to high-dimensional flow cytometry
- Anyone seeking to have a deeper understanding of high-dimensional flow technologies
Certificate of attendance
All webinar participants can request a certificate of attendance, including a learning outcomes summary, for continuing education purposes.
Presenter: Caroline E. Roe, MLI (Managing Director, Cancer and Immunology Core, Vanderbilt University)
Caroline Roe received her BS.c. in Genetics, Cell Biology, and Development from the University of Minnesota-Twin Cities, and Master of Laboratory Investigation from Vanderbilt University in Nashville, Tennessee, where she has managed the Mass Cytometry Center of Excellence since its inception in 2017. As director of the Cancer and Immunology Core, her focus is on increasing both the standardization and accessibility of cutting-edge cytometry techniques for application across a broad range of basic and translational research projects.
Moderator: Charlie Carter (Associate Editor, SelectScience)
